1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. CAPLIN POINT LABORATORIES LTD.
Caplin Point Laboratories Ltd.
NSE: CAPLIPOINT | BSE: 524742
Mid-range Performer
In 1 Starfolio Basket
Download real time
Iran War Impact
2028.00 2.10 (0.10%)
35.17% Gain from 52W Low
95,665
NSE+BSE Volume

NSE 22 May, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
Dividend
Caplin Point Labs has an upcoming dividend of ₹4.000 per share due on 29 May 2026 See details